Related Experiment Video
Updated: Dec 15, 2025

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
Published on: March 8, 2012
"It takes time to build trust": a survey Ontario's school-based HPV immunization program ten years
Eve Dubé1,2,3, Sarah Wilson4,5,6, Dominique Gagnon1
1Département des risques biologiques et de la santé au travail, Institut National de Santé Publique du Québec (INSPQ) , Québec, Canada.
Ontario
Area of Science:
- Public Health
- Vaccinology
- Epidemiology
Background:
- The human papillomavirus (HPV) vaccine is crucial for preventing HPV-related cancers.
- School-based vaccination programs are a key strategy for achieving high HPV vaccine coverage.
Purpose of the Study:
- To describe the organization and delivery of Ontario's school-based HPV vaccination program from the perspective of local public health units (PHUs).
- To identify challenges and facilitators in implementing the HPV vaccination program in schools.
Main Methods:
- An online survey was distributed to Vaccine Preventable Diseases (VPD) managers in all 35 Ontario PHUs.
- The survey assessed program delivery, provider training, communication strategies, coverage assessment, and perceived strengths and challenges.
- Descriptive statistics and thematic content analysis were used to analyze the data.
Main Results:
- Eighteen PHUs responded, with all providing the HPV vaccine in publicly funded schools; only 6 could offer it in private schools.
- Locally developed fact sheets and Q&As were primary communication tools for parents, students, and school personnel.
- Key barriers included limited resources, negative vaccine perceptions, logistical issues with consent and delivery, and the program's voluntary nature.
Conclusions:
- Local public health units face significant barriers in delivering school-based HPV vaccination programs.
- Logistical challenges, public and school staff perceptions, and the non-mandatory status of the vaccine impede program success.
More Related Videos
06:57Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis
Published on: June 14, 2019
08:04Development of an IFN-γ ELISpot Assay to Assess Varicella-Zoster Virus-specific Cell-mediated Immunity Following Umbilical Cord Blood Transplantation
Published on: July 9, 2014
Related Concept Videos
Vaccinations
Longitudinal Research
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Levels of Health Promotion and Illness Prevention
In primary prevention, actions taken before disease onset prevent the disease from...